What do systematic reviews say?

21 questions · 21 findings · 5 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 18 · 85.7%GRADE not reported 1 · 4.8%Very low 1 · 4.8%Low 0 · 0%Moderate 1 · 4.8%High 0 · 0%

IFN‐α + PUVA vs PUVA

Improvement of quality of life · people with mycosis fungoides

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for mycosis fungoides 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IFN‐α + acitretin vs IFN‐α + PUVA

Improvement of quality of life · people with mycosis fungoides

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for mycosis fungoides 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

PUVA maintenance vs no maintenance

Improvement of quality of life · people with mycosis fungoides

1 finding from 1 review

Interventions for mycosis fungoides 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
GRADE not reported

Extracorporeal photopheresis vs PUVA

Improvement of quality of life · people with mycosis fungoides

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for mycosis fungoides 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bexarotene + PUVA vs PUVA

Improvement of quality of life · people with mycosis fungoides

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for mycosis fungoides 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs Conventional treatment

Improvement in quality of life · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs placebo

Improvement in quality of life · eczema

The review found no eligible studies for this question.

1 finding from 1 review

Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Topical vitamin D derivative vs placebo

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Puvatherapy vs placebo or no treatment

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

UVA1 vs narrowband UVB

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Triamcinolone acetonide 0.1% cream with occlusive dressing vs clobetasol cream 0.05% cream

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etretinate vs placebo or no treatment

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etretinate with PUVA therapy as co‐intervention vs placebo with PUVA therapy

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etretinate vs PUVA

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Alitretinoin vs placebo

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Etanercept vs placebo

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ustekinumab vs placebo

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Guselkumab vs placebo

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Secukinumab vs placebo

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic palmoplantar pustulosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dietary interventions vs usual care

Change in DLQI score (LOCF) · psoriasis

1 finding from 1 review

Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 36 participants
Moderate